Physician profile
Pedro Arturo Villablanca Spinetto
NPI 1518254630
$620,363.69
in general payments reported to CMS, 2019-2025
28 companies · $166K in 2025
The $166K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $691 · 2021: $69K · 2022: $46K · 2023: $151K · 2024: $176K · 2025: $166K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $269K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $76K · Travel and Lodging: $72K · Honoraria: $56K · Food and Beverage: $20K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $269,230.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $76,303.13 |
| Travel and Lodging | $71,819.82 |
| Honoraria | $56,450.00 |
| Food and Beverage | $19,541.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $442,371.07 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Pascal |
| Abiomed | $81,066.02 | 2021-2025 | Impella |
| Medtronic, INC. | $30,694.85 | 2022-2025 | Corevalve Evolut R |
| Angiodynamics, INC. | $26,568.44 | 2021-2025 | Alphavac, Angiovac |
| Teleflex LLC | $19,084.15 | 2021-2025 | Manta, Guideliner, Trapliner |
| Medtronic Vascular, INC. | $5,849.14 | 2019-2020 | |
| Abbott Laboratories | $5,766.34 | 2019-2025 | Amplatzer, Triclip, Portico |
| Arrow International, INC. | $3,939.97 | 2023 | |
| Boston Scientific Corporation | $2,568.75 | 2019-2025 | Watchman Access System, Sentinel, Ranger |
| Imperative Care, INC | $310.24 | 2025 | Symphony Catheter, Truvic Generator, Hotshot Controller |
| Bard Peripheral Vascular, INC. | $266.33 | 2021-2025 | True Flow |
| Biosense Webster, INC. | $264.71 | 2023-2025 | Na, Carto 3, Nuvision Ice Catheter |
| Shockwave Medical, INC | $248.74 | 2025 | |
| Amgen INC. | $246.22 | 2022-2024 | Repatha |
| Cardiovascular Systems INC. | $192.28 | 2019-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $167.14 | 2021-2025 | (O49) Image Guided Therapy Und, Igt Devices Undivided |
| Cook Medical LLC | $166.79 | 2019 | |
| W. L. Gore & Associates, INC. | $145.40 | 2021 | |
| Livanova USA, INC. | $144.19 | 2022 | |
| Procyrion, INC. | $81.27 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $51.32 | 2019-2025 | Lifevest |
| Stryker Corporation | $36.85 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Opsens INC. | $34.42 | 2022 | |
| Inari Medical, INC. | $30.76 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Terumo Medical Corporation | $25.83 | 2023 | Glidewire |
| Cardiva Medical, INC. | $21.94 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Chiesi USA, INC. | $20.53 | 2024 | Cleviprex, Kengreal |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pedro Villablanca Spinetto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.